Pipecuronium bromide

Also known as: Arduan, RGH-1106, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) dibromide, Pipecurium bromide, Pipecurinium bromide, Pipecuroniumbromid, Ardtm

Pipecuronium bromide (CAS 52212-02-9) is a compound in the Organohalogen Compounds category listed in the Jingsj chemical database. It has the molecular formula C35H62Br2N4O4 and a molecular weight of 762.69900 g/mol. Key properties include a melting point of 262-264ºC and a density of 1.329. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 52212-02-9
Jingsj CID: J-38285-6
Molecular Formula: C₃₅H₆₂Br₂N₄O₄
Molecular Weight: 762.69900 g/mol
Category: Organohalogen Compounds
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	262-264ºC
Density	1.329
Exact Mass	760.31400
PSA	59.08000

Activity & Biological Data

Target	nAChR[4][5]
Additional Information	[1]. Tassonyi E, et al. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial. Anesth Analg. 2015 Aug;121(2):373-80. [2]. Tassonyi E, et al. Reversal of Deep Pipecuronium-Induced Neuromuscular Block With Moderate Versus Standard Dose of Sugammadex: A Randomized, Double-Blind, Noninferiority Trial. Anesth Analg. 2018 Dec;127(6):1344-1350. [3]. Alánt O, et al. First clinical experience with a new neuromuscular blocker pipecurium bromide. Arzneimittelforschung. 1980;30(2a):374-9. [4]. Töröcsik A, et al. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur J Pharmacol. 1991 Sep 24;202(3):297-302. [5]. Kárpáti E, et al. Investigation of neuromuscular blocking agents at Richter Ltd. Acta Pharm Hung. 2002;72(1):37-48.

Target

nAChR[4][5]

Additional Information

[1]. Tassonyi E, et al. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial. Anesth Analg. 2015 Aug;121(2):373-80. [2]. Tassonyi E, et al. Reversal of Deep Pipecuronium-Induced Neuromuscular Block With Moderate Versus Standard Dose of Sugammadex: A Randomized, Double-Blind, Noninferiority Trial. Anesth Analg. 2018 Dec;127(6):1344-1350. [3]. Alánt O, et al. First clinical experience with a new neuromuscular blocker pipecurium bromide. Arzneimittelforschung. 1980;30(2a):374-9. [4]. Töröcsik A, et al. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur J Pharmacol. 1991 Sep 24;202(3):297-302. [5]. Kárpáti E, et al. Investigation of neuromuscular blocking agents at Richter Ltd. Acta Pharm Hung. 2002;72(1):37-48.

Customs & Trade Information

HS Code	29322980

Frequently Asked Questions

What is the CAS number of Pipecuronium bromide?

The CAS number of Pipecuronium bromide is 52212-02-9.

What are the molecular formula and molecular weight of Pipecuronium bromide?

Pipecuronium bromide has molecular formula C35H62Br2N4O4 and molecular weight 762.69900 g/mol.

What are the upstream and downstream products of Pipecuronium bromide?

For Pipecuronium bromide, Upstream Products: Methyl bromide.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Pipecuronium bromide (CAS 52212-02-9)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-38285-6 (accessed 2026-11-06).

Data for reference only; verify product details with suppliers before purchase.